0 Registered Patient Population |
0% of Total Population Represented by Patients |
156 Total Medical Retail Locations Currently in Operation |
N/A Patients : Retail |
Navigating Mississippi State Laws:
Patients and Caregivers: Enrolling and Accessing Medical Cannabis
Medical Professionals: Procedures for recommending Medical Cannabis
Policymakers and Advocates: Actions Needed to Improve Laws for Patients
NOTICE: It can be challenging for patients to determine which businesses offering cannabis products are licensed and approved by the state. Review this list of medical cannabis retailers to find out where to purchase regulated cannabis in Mississippi.
Traveling? Get more information about traveling in the US here.
Get involved locally!
Background on State Laws
In 2014, Mississippi enacted HB 1231, which created an affirmative defense for the possession and use of CBD oil solely for patients who suffer from debilitating epilepsy. Known as “Harper Grace’s Law,” the bill only provides legal protections to this extremely limited patient population only if the CBD oil was either obtained from or tested by the National Center for Natural Products Research at the University of Mississippi, and dispensed by the Department of Pharmacy Services at the University of Mississippi Medical Center. Today, as a registered patient in Mississippi, you will have an affirmative defense in court if you are arrested for the possession of cannabis. In 2022, Mississippi passed the Medical Cannabis Act, S.B. 2095 creating the Mississippi Medical Cannabis Program (MMCP) regulated by MS Department of Health (MSDH) allowing patients and caregivers to possess up to 3.5 ounces at one time and purchase 6 Mississippi Medical Cannabis Equivalency Units (MMCEUs). A week which includes 3.5 grams of medical cannabis flower, 1 gram of medical cannabis concentrate; or 100 milligrams of THC in an infused product & 24 a month approx. 3 ounces. The first legal sale of medical cannabis in the state was not made until January 2023.
The state of Mississippi does not recognize out-of-state patient registrations but visiting patients can register with the state 30 days before arriving in the state. Growing cannabis at home remains illegal in the state of Mississippi.
Here is a breakdown of how Mississippi fared in ASA’s Annual State of the States Report, which evaluates the effectiveness of each state cannabis program from a patient perspective and assigns a grade using a rubric that reflects the key issues affecting patient access. Medical cannabis laws are constantly changing, ASA’s policy recommendations for Mississippi can be found below. For policy updates Sign Up here or Take Action!
Patient Rights and Civil Protections |
20/100 |
|
Arrest Protection |
0/25 |
Affirmative Defense |
20/20 |
Parental Rights Protections |
0/20 |
DUI Protections |
0/10 |
Employment Protections |
0/20 |
Explicit Privacy Standards |
0/5 |
|
Access to Medicine |
0/100 |
|
Authorizes Retail Access |
0/10 |
Alternative Accessibility Methods |
0/20 |
- Authorizes Delivery |
0/10 |
- Authorizes Curbside Pickup |
0/10 |
Personal Cultivation |
0/15 |
Collective Gardening |
0/5 |
Sufficient Number of Licensed Retailers |
0/30 |
Reciprocity |
0/20 |
|
Program Functionality |
20/100 |
|
Legal Protections Within Reasonable Time Frame |
0/20 |
Reasonable Possession Limits |
10/10 |
Reasonable Purchase Limits |
0/10 |
Telemedicine for Physician Certifications |
0/15 |
Patient and Physician Representation in Program Decision Making |
0/20 |
Reasonable Caregiver Standards |
3/5 |
- Background Checks |
2/2 |
- Number of Caregivers |
1/3 |
Reasonable Physician Standards |
5/5 |
Access to Administration Methods |
2/10 |
- Allows Dried Flower |
0/5 |
- Allows Edibles, Concentrates, and Other Forms |
2/5 |
Provides Access to Minors on School Grounds |
0/5 |
|
Affordability |
40/100 |
|
Sales Tax Break for Patients and Caregivers |
0/20 |
Covered by State Insurance or Health Aid |
0/20 |
Reasonable Registration Fees |
20/20 |
Financial Hardship Waivers or Discounts |
20/20 |
Donation Program |
0/10 |
Allows Multi-Year Registrations |
0/10 |
|
Health and Social Equity |
11/100 |
|
State Program Protections |
0/25 |
Housing Protections |
0/25 |
Access for Minors |
10/10 |
Access in Underserved Areas |
0/10 |
List of Qualifying Conditions is Exhaustive or All Inclusive |
1/10 |
Allows Patients to Medicate Where they Choose |
0/10 |
Organ Transplants |
0/5 |
Ownership or Employment Restrictions |
0/5 |
|
Consumer Protection and Product Safety |
91/200 |
|
Cultivation Operations |
23/50 |
Quality Management Systems |
0/10 |
Staff Training |
10/10 |
Standard Operating Procedures |
0/8 |
- Facility and Equipment Sanitation |
0/1 |
- Workplace Safety |
0/1 |
- Storage |
0/1 |
- Batch and Lot Tracking |
0/1 |
- Security |
0/1 |
- Waste Disposal |
0/1 |
- Water Management |
0/1 |
- Records Management |
0/1 |
Pesticide Usage Limitations |
2/2 |
Environmental Impact Regulations |
0/2 |
Required Testing |
8/8 |
- Cannabinoids |
1/1 |
- Terpenes |
1/1 |
- Microbials |
1/1 |
- Aflatoxins |
1/1 |
- Pesticides |
1/1 |
- Heavy Metals |
1/1 |
- Foreign Matter |
1/1 |
- Moisture Content/ Water Activity |
1/1 |
Packaging and Labeling |
3/3 |
- Cannabinoids |
1/1 |
- Terpenes |
1/1 |
- Pesticides |
1/1 |
Complaints, Adverse Event Reporting, and Recall Protocol |
0/7 |
Manufacturing Operations |
24/50 |
Quality Management Systems |
0/10 |
Staff Training |
10/10 |
Standard Operating Procedures |
0/7 |
- Facility and Equipment Sanitation |
0/1 |
- Workplace Safety |
0/1 |
- Storage |
0/1 |
- Batch and Lot Tracking |
0/1 |
- Security |
0/1 |
- Waste Disposal |
0/1 |
- Records Management |
0/1 |
Environmental Impact Regulations |
0/3 |
Required Testing |
9/10 |
- Cannabinoids |
1/1 |
- Terpenes |
1/1 |
- Microbials |
1/1 |
- Aflatoxins |
1/1 |
- Pesticides |
1/1 |
- Heavy Metals |
1/1 |
- Residual Solvents |
1/1 |
- Homogeneity |
0/1 |
- Foreign Matter |
1/1 |
- Water Activity |
1/1 |
Packaging and Labeling |
5/5 |
- Cannabinoids |
1/1 |
- Terpenes |
1/1 |
- Ingredients |
1/1 |
- Allergens |
1/1 |
- Nutritional Content |
1/1 |
Complaints, Adverse Event Reporting and Recall Protocol |
0/5 |
Dispensary Operations |
0/50 |
Staff Training |
0/20 |
Standard Operating Procedures |
0/7 |
- Facility Sanitation |
0/1 |
- Workplace Safety |
0/1 |
- Storage |
0/1 |
- Batch and Lot Tracking |
0/1 |
- Security |
0/1 |
- Waste Disposal |
0/1 |
- Records Management |
0/1 |
Product Testing |
0/10 |
- Product Meets Requirements Before Sale |
0/5 |
- COA Disclosure |
0/5 |
Complaints, Adverse Event Reporting and Recall Protocol |
0/13 |
Laboratory Operations |
44/50 |
Independent or Third-Party |
5/5 |
Laboratory Sampling |
5/5 |
Method Validation |
4/4 |
Quality Management Systems |
5/5 |
Staff Training |
20/20 |
Standard Operating Procedures |
5/7 |
- Facility and Equipment Sanitation |
0/1 |
- Equipment and Instrument Calibration |
1/1 |
- Workplace Safety |
0/1 |
- Sample Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
1/1 |
- Records Management |
1/1 |
Result Reporting |
0/4 |
|
Score Penalties |
40/100 |
|
Gives Regulatory Preference to Adult Use |
0/20 |
Classifies Cannabis as a Medicine of Last Resort |
15/15 |
Administrative or Supply Problems |
15/15 |
Requires Vertical Integration |
0/10 |
Creates New Criminal Penalties for Patients |
0/10 |
Limits Patients to a Single Retailer |
0/10 |
No System for Adding Qualifying Conditions |
0/10 |
Imposes Bans or Limits on THC |
5/5 |
Imposes Bans or Limits on CBD |
5/5 |
|
Excerpted from ASA's 2022 State of the States Report. |